Marc A. Began - May 29, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role
VP & General Counsel
Signature
/s/ Ian Mcleod (by power of attorney)
Stock symbol
ABMD
Transactions as of
May 29, 2021
Transactions value $
-$136,598
Form type
4
Date filed
6/2/2021, 04:46 PM
Previous filing
May 27, 2021
Next filing
Jul 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock, $0.01 par value Tax liability -$137K -480 -7.42% $284.58 5.99K May 29, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ABMD Stock Option (Right to Buy) 7K May 29, 2021 Common Stock 0 $266.39 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 5.13K May 29, 2021 Common Stock 0 $223.90 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 2.96K May 29, 2021 Common Stock 0 $283.88 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.